These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chronic Adrenergic Stress Contributes to Metabolic Dysfunction and an Exhausted Phenotype in T Cells in the Tumor Microenvironment. Qiao G; Chen M; Mohammadpour H; MacDonald CR; Bucsek MJ; Hylander BL; Barbi JJ; Repasky EA Cancer Immunol Res; 2021 Jun; 9(6):651-664. PubMed ID: 33762351 [TBL] [Abstract][Full Text] [Related]
3. β2-adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanoma. Schuster C; Akslen LA; Straume O Cancer Med; 2023 Sep; 12(17):17891-17900. PubMed ID: 37551424 [TBL] [Abstract][Full Text] [Related]
4. β-Adrenergic Signaling in Mice Housed at Standard Temperatures Suppresses an Effector Phenotype in CD8 Bucsek MJ; Qiao G; MacDonald CR; Giridharan T; Evans L; Niedzwecki B; Liu H; Kokolus KM; Eng JW; Messmer MN; Attwood K; Abrams SI; Hylander BL; Repasky EA Cancer Res; 2017 Oct; 77(20):5639-5651. PubMed ID: 28819022 [TBL] [Abstract][Full Text] [Related]
5. β2-Adrenergic Receptor Mediated Inhibition of T Cell Function and Its Implications for CAR-T Cell Therapy. Farooq MA; Ajmal I; Hui X; Chen Y; Ren Y; Jiang W Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629018 [TBL] [Abstract][Full Text] [Related]
6. Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity. Gandhi S; Pandey MR; Attwood K; Ji W; Witkiewicz AK; Knudsen ES; Allen C; Tario JD; Wallace PK; Cedeno CD; Levis M; Stack S; Funchain P; Drabick JJ; Bucsek MJ; Puzanov I; Mohammadpour H; Repasky EA; Ernstoff MS Clin Cancer Res; 2021 Jan; 27(1):87-95. PubMed ID: 33127652 [TBL] [Abstract][Full Text] [Related]
8. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis. Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026 [TBL] [Abstract][Full Text] [Related]
9. Leveraging β-Adrenergic Receptor Signaling Blockade for Improved Cancer Immunotherapy Through Biomimetic Nanovaccine. Yang C; He Y; Chen F; Zhang F; Shao D; Wang Z Small; 2023 Apr; 19(14):e2207029. PubMed ID: 36703529 [TBL] [Abstract][Full Text] [Related]
10. Environmental eustress modulates β-ARs/CCL2 axis to induce anti-tumor immunity and sensitize immunotherapy against liver cancer in mice. Liu C; Yang Y; Chen C; Li L; Li J; Wang X; Chu Q; Qiu L; Ba Q; Li X; Wang H Nat Commun; 2021 Sep; 12(1):5725. PubMed ID: 34593796 [TBL] [Abstract][Full Text] [Related]
11. β2-adrenergic receptor signaling regulates metabolic pathways critical to myeloid-derived suppressor cell function within the TME. Mohammadpour H; MacDonald CR; McCarthy PL; Abrams SI; Repasky EA Cell Rep; 2021 Oct; 37(4):109883. PubMed ID: 34706232 [TBL] [Abstract][Full Text] [Related]
12. Role of host β1- and β2-adrenergic receptors in a murine model of B16 melanoma: functional involvement of β3-adrenergic receptors. Sereni F; Dal Monte M; Filippi L; Bagnoli P Naunyn Schmiedebergs Arch Pharmacol; 2015 Dec; 388(12):1317-31. PubMed ID: 26285646 [TBL] [Abstract][Full Text] [Related]
13. MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma. de Azevedo RA; Shoshan E; Whang S; Markel G; Jaiswal AR; Liu A; Curran MA; Travassos LR; Bar-Eli M Oncoimmunology; 2020 Dec; 9(1):1846915. PubMed ID: 33344042 [TBL] [Abstract][Full Text] [Related]
14. Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade. Lee WS; Kim DS; Kim JH; Heo Y; Yang H; Go EJ; Kim JH; Lee SJ; Ahn BC; Yum JS; Chon HJ; Kim C J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764365 [TBL] [Abstract][Full Text] [Related]
15. Targeted deletion of CD244 on monocytes promotes differentiation into anti-tumorigenic macrophages and potentiates PD-L1 blockade in melanoma. Kim J; Kim TJ; Chae S; Ha H; Park Y; Park S; Yoon CJ; Lim SA; Lee H; Kim J; Kim J; Im K; Lee K; Kim J; Kim D; Lee E; Shin MH; Park SI; Rhee I; Jung K; Lee J; Lee KH; Hwang D; Lee KM Mol Cancer; 2024 Feb; 23(1):45. PubMed ID: 38424542 [TBL] [Abstract][Full Text] [Related]